Showing results (211-220 of 261) with videos related to
Sort By:
Pageof 27
Wiener Klinische Wochenschrift|July 15, 2018
Ludwig Boltzmann Cluster Oncology (LBC ONC): first 10 years and future perspectivesPeter Valent, Emir Hadzijusufovic, Thomas Grunt, et al.Blood|August 11, 2020
Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosisGeorg Greiner, Bettina Sprinzl, Aleksandra Górska, et al.Gastroenterology|June 13, 2012
Hepatoma cells from mice deficient in glycine N-methyltransferase have increased RAS signaling and activation of liver kinase B1Nuria Martínez-López, Juan L García-Rodríguez, Marta Varela-Rey, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2018
Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic CholangiocarcinomaXinhua Song, Xianqiong Liu, Haichuan Wang, et al.Journal of Experimental & Clinical Cancer Research : CR|September 6, 2024
HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinomaAntonio Cigliano, Isabella Gigante, Marina Serra, et al.Gut|September 12, 2021
Histone H3K27 demethylase KDM6A is an epigenetic gatekeeper of mTORC1 signalling in cancerSteffie Revia, Agnieszka Seretny, Lena Wendler, et al.Cancers|May 28, 2022
Adverse Events in 1406 Patients Receiving 13,780 Cycles of Azacitidine within the Austrian Registry of Hypomethylating Agents-A Prospective Cohort Study of the AGMT Study-GroupMichael Leisch, Michael Pfeilstöcker, Reinhard Stauder, et al.Haematologica|April 26, 2015
Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trialUlrich Jaeger, Marek Trneny, Helen Melzer, et al.Genes, Chromosomes & Cancer|April 23, 2020
NTRK testing: First results of the QuiP-EQA scheme and a comprehensive map of NTRK fusion variants and their diagnostic coverage by targeted RNA-based NGS assaysMartina Kirchner, Julia Glade, Ulrich Lehmann, et al.Journal of Experimental & Clinical Cancer Research : CR|June 2, 2022
The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human diseaseAntonio Cigliano, Shanshan Zhang, Silvia Ribback, et al.Pageof 27